Investing Center Preview – Manage your investments and watch your net worth grow.
DSNKY:OTC Pink - Limited Information – Large Cap Stock ()
Daiichi Sankyo Co Ltd – DSNKY Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
25.21 | 1.33 (+5.57%) | 22.47 - 42.48 | 303.5 thousand |
Market data as of 3:59PM 04/01/25. Quotes are delayed by at least 15 min.
Overview - DSNKY
Open | 25.32 |
---|---|
Previous Close | 23.88 |
Day's Range | 24.77 - 25.35 |
Market Cap | 48.1B |
Avg Volume (10 Day) | 305.6K |
Price/Earnings (Trailing 12 Mo.) | 28.5x |
Earnings Per Share (Trailing 12 Mo.) | 23.555 |
Dividend Yield | 0.1966 (1.53%) |
One-Click Scorecard - DSNKY


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Neutral |
---|---|
Avoids excess debt? | Neutral |
Converting sales to profits? | Neutral |
Shareholder's money handled rationally? | Neutral |
Increased shareholder value? | Neutral |
Consistently increased owner earnings? | Neutral |
Sells at 25% discount to intrinsic value? | Neutral |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Neutral |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Neutral |
Stock is undervalued? | Neutral |
Have investors caught on? | Neutral |
Has support of institutional investors? | Neutral |
Has sufficient liquidity? | Neutral |
Latest Headlines - DSNKY
DESTINY-Gastric05 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously Untreated HER2 Positive Advanced Gastric Cancer
Business Wire - Monday 03/31/2025 8:00 AM ET
Industry Position - DSNKY
DSNKY | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 25.28% | |
Net Income Growth (1yr) | 83.84% | |
Total Debt/Equity | 0.06 | |
LT Debt/Equity | 0.06 | |
Earnings Yield | 3.51% | |
Price/Sales | 3.91 |
Competitors - DSNKY
Company | Last | Change |
---|
Data is delayed by at least 15 min.